Home › Heart Failure › Iowa › Des Moines
Heart Failure clinical trials in Des Moines, IA
4 studies for Heart Failure are looking for participants at sites in and around Des Moines (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
RecruitingPhase 3
- The Iowa Clinic, PC, West Des Moines · 6 mi away
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
RecruitingPhase 3
- The Iowa Clinic, PC, West Des Moines · 6 mi away
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
RecruitingObservational study
- West Des Moines, West Des Moines · 6 mi away
Assessment of CCM in HF With Higher Ejection Fraction
Recruiting
- MercyOne Iowa Heart, West Des Moines · 6 mi away
About Heart Failure
Heart failure, or congestive heart failure (CHF), means the heart can't pump enough blood. Learn about the signs, symptoms, and causes.
More about Heart Failure on MedlinePlus
Heart Failure trials in other cities
- New York City, NY51 studies
- Boston, MA44 studies
- Dallas, TX42 studies
- Houston, TX36 studies
- Cleveland, OH33 studies
- Chicago, IL31 studies
- Philadelphia, PA31 studies
- San Francisco, CA29 studies
- St. Louis, MO26 studies
- Durham, NC26 studies
- Kansas City, MO25 studies
- Atlanta, GA25 studies
Other studies in Des Moines
- Non-Small Cell Lung Cancer11 studies
- Lung Cancer10 studies
- Colorectal Cancer8 studies
- Chronic Lymphocytic Leukemia8 studies
- Breast Cancer8 studies
- Overweight6 studies
- Bladder Cancer6 studies
- Prostate Cancer5 studies
- Multiple Myeloma5 studies
- Melanoma5 studies
- Cardiovascular Disease5 studies
- Obesity5 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.